55 related articles for article (PubMed ID: 36896655)
1. Epidemiology and prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium in a tertiary hospital from Madrid, Spain.
Maldonado-Barrueco A; Rodríguez-Ayala M; Grandioso-Vas D; García-Clemente P; Guedez-López GV; García-Rodríguez J; Quiles-Melero I
Rev Esp Quimioter; 2023 Jun; 36(3):310-313. PubMed ID: 36896655
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.
Tagg KA; Jeoffreys NJ; Couldwell DL; Donald JA; Gilbert GL
J Clin Microbiol; 2013 Jul; 51(7):2245-9. PubMed ID: 23658265
[TBL] [Abstract][Full Text] [Related]
3. Detection of Macrolide and/or Fluoroquinolone Resistance Genes in
Ljubin-Sternak S; Meštrović T; Marijan T; Anušić M; Šuto S; Vraneš J
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674404
[No Abstract] [Full Text] [Related]
4. Mycoplasma genitalium in Symptomatic Male Urethritis: Macrolide Use Is Associated With Increased Resistance.
Li Y; Su X; Le W; Li S; Yang Z; Chaisson C; Madico G; Gong X; Reed GW; Wang B; Rice PA
Clin Infect Dis; 2020 Feb; 70(5):805-810. PubMed ID: 30972419
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.
Jensen JS; Fernandes P; Unemo M
Antimicrob Agents Chemother; 2014 Jun; 58(6):3151-6. PubMed ID: 24637681
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin and moxifloxacin resistance determinants in Mycoplasma genitalium in Lleida, Spain.
Fraile García L; Aramburu Arnuelos J; López González E; Bellés-Bellés A; Muñoz Santa A; Sánchez Báscones E; Mormeneo Bayo S; Bernet Sánchez A; Prats Sánchez I; Cumplido Portillo A; García González M
Rev Esp Quimioter; 2024 Jun; 37(3):270-273. PubMed ID: 38591493
[TBL] [Abstract][Full Text] [Related]
7. Estimation of antimicrobial resistance of
De Baetselier I; Smet H; Kehoe K; Loosen I; Reynders M; Mansoor I; Filippin L; Cauchie M; Van Even E; Makki N; Schiettekatte G; Vandewal W; Glibert B; Matheeussen V; Van der Beken Y; Cartuyvels R; Steyaert S; Lemmens A; Garrino MG; Paridaens H; Lazarova E; Lissoir B; Deffontaine M; Heinrichs A; Saegeman V; Padalko E; Lecompte A; Vanden Berghe W; Kenyon C; Van den Bossche D
Euro Surveill; 2024 Feb; 29(7):. PubMed ID: 38362626
[TBL] [Abstract][Full Text] [Related]
8. Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States.
Getman D; Jiang A; O'Donnell M; Cohen S
J Clin Microbiol; 2016 Sep; 54(9):2278-83. PubMed ID: 27307460
[TBL] [Abstract][Full Text] [Related]
9. Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia.
Ertl NG; Anderson TK; Pardo CJ; Maidment TI; Murray GL; Bradshaw CS; Whiley DM; Sweeney EL
J Antimicrob Chemother; 2024 Feb; 79(2):467-469. PubMed ID: 38102067
[No Abstract] [Full Text] [Related]
10. Single gene targeted nanopore sequencing enables simultaneous identification and antimicrobial resistance detection of sexually transmitted infections.
Zhou L; Lopez Rodas A; Llangarí LM; Romero Sandoval N; Cooper P; Sadiq ST
PLoS One; 2022; 17(1):e0262242. PubMed ID: 35061780
[TBL] [Abstract][Full Text] [Related]
11. Mycoplasma genitalium infection and resistance-associated mutations to macrolides and fluoroquinolones among high-risk patients in Taiwan.
Tsai MJ; Sun HY; Su LH; Lin KY; Liu WD; Huang YS; Chen GJ; Su YC; Liu WC; Chang SY; Hung CC
J Microbiol Immunol Infect; 2024 May; ():. PubMed ID: 38777653
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of treatment with two weeks of doxycycline on macrolide-resistant strains of Mycoplasma genitalium: a retrospective observational study.
Gossé M; Nordbø SA; Pukstad B
BMC Infect Dis; 2021 Dec; 21(1):1225. PubMed ID: 34876039
[TBL] [Abstract][Full Text] [Related]
13.
Lavey SC; Cassel B; Munson E
Clin Med Res; 2024 Mar; 22(1):13-18. PubMed ID: 38609142
[No Abstract] [Full Text] [Related]
14. Diagnostic and resistance testing for Mycoplasma genitalium: what will it take?
Manhart LE
Clin Infect Dis; 2014 Jul; 59(1):31-3. PubMed ID: 24729505
[No Abstract] [Full Text] [Related]
15. Macrolide and fluoroquinolone resistance associated mutations in Mycoplasma genitalium in men who have sex with men attending STI clinic: A pilot study from India.
Biswal D; Gupta S; Sethi S; Singh S; Khanna N; Dhawan B
Indian J Dermatol Venereol Leprol; 2024 May; ():1-4. PubMed ID: 38899414
[TBL] [Abstract][Full Text] [Related]
16. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment.
Ross JD; Jensen JS
Sex Transm Infect; 2006 Aug; 82(4):269-71. PubMed ID: 16877571
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and incidence of Mycoplasma genitalium infection: a systematic review protocol.
McCullough A; Palokas M
JBI Evid Synth; 2024 Apr; 22(4):700-705. PubMed ID: 37909115
[TBL] [Abstract][Full Text] [Related]
18. Is It Time for the United States and Canada to Reconsider Macrolides as the First-line Empiric Treatment for Males With Symptomatic Urethritis?
Singh AE; Manhart L
Clin Infect Dis; 2020 Feb; 70(5):811-813. PubMed ID: 30972414
[No Abstract] [Full Text] [Related]
19. Increase in gonococcal arthritis in Madrid, Spain, 2022-2023.
Maldonado-Barrueco A; Sanz-González C; Rico-Nieto A; Grandioso-Vas D; Ruiz-Bastián M; Falces-Romero I; Cacho-Calvo J; Quiles-Melero I
Int J STD AIDS; 2024 May; ():9564624241254877. PubMed ID: 38748748
[TBL] [Abstract][Full Text] [Related]
20. Prevalence studies of
Panos G
Germs; 2018 Mar; 8(1):8-11. PubMed ID: 29564243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
